5 unknown. 5 Phase 2, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Unknown 5 |
| Phase 3 | 3 | Unknown 3 |
Follow Myalgia: new trials by email Literature Review of Myalgia trials Research Report on Myalgia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CBD (Cannabidiol)/THC (Tetrahydrocannabinol) Solution as a Pharmacological Strategy for Patients With Fibromyalgia (FibroCann) cannabidiol and tetrahydrocannabinol, Placebo - Fibromyalgia | Phase 2 / Phase 3 | Unknown | FG Brasil LTDA | 40 | 2022-04-15 | 2022-04-11 |
| Arnica and the Management of Pain in Acute Musculoskeletal Extremity Injuries Arnica, Placebo - Pain, Muscle, Pain, Acute | Phase 2 / Phase 3 | Unknown | Children's Hospitals and Clinics of Minnesota | 324 | 2021-07-15 | 2022-03-17 |
| Masseter Myofascial Pain Relief Following an Intra-muscular Injection With Botulinum Toxin Type A. Botulinum toxin type A, saline solution - Myalgia, Myofascial Pain | Phase 2 | Unknown | Region Örebro County | 48 | 2020-07-01 | 2020-06-11 |
| Prophylactic Gabapentin for Taxane-Induced Arthralgia and Myalgia Syndrome in Breast Cancer Patients Undergoing Adjuvant Chemotherapy Gabapentin 300mg - Invasive Breast Cancer, Chemotherapeutic Toxicity | Phase 2 / Phase 3 | Unknown | British Columbia Cancer Agency | 46 | 2018-07-02 | 2018-06-25 |
| Evaluation of Loratadine for Prevention of Pegfilgrastim-Induced Pain Loratadine, placebo - Pegfilgrastim-induced Back and Leg Pain | Phase 2 | Unknown | University of Vermont | 55 | 2011-05-01 | 2013-01-24 |
Arthralgia (2) · Acute Pain (1) · Agnosia (1) · Fibromyalgia (1)
Muscular Diseases (5) · Musculoskeletal Diseases (5) · Musculoskeletal Pain (5) · Nervous System Diseases (5) · Neurologic Manifestations (5) · Neuromuscular Diseases (5) · Pain (5) · Pathological Conditions, Signs and Symptoms (5) · Signs and Symptoms (5) · Joint Diseases (2) · Neurobehavioral Manifestations (1) · Perceptual Disorders (1) · Rheumatic Diseases (1)
Arnicae flos extract (1) · Botulinum Toxins, Type A (1) · Cannabidiol (1) · Dronabinol (1) · Gabapentin (1) · Loratadine (1) · Saline Solution (1)
British Columbia Cancer Agency (1) · Children's Hospitals and Clinics of Minnesota (1) · FG Brasil LTDA (1) · Region Örebro County (1) · University of Vermont (1)
United States (2)
Daniel Ovesson, DDS (1) · Manu Madhok, MD, MPH (1) · Mohamad Schumann, DDS (1) · Osvaldo Antonio H Junior (1) · Steven M Grunberg, MD (1)